Cart
0
It is not a small, embarrassing footnote to midlife. It is a measurable change in tissue, chemistry and blood supply — one with a clinical name, a predictable trajectory, and a short list of things that reliably help.
The first sign is rarely dramatic. A faint drag of cotton against skin that used to glide. A three-second sting in the shower. Most women allude to vaginal dryness symptoms due to a season rather than a day — the year the fabric started to catch, the winter the urinary infections kept returning. Almost nobody dates it to a diagnosis, because for most there has never been one.
QUICK ANSWER
As estrogen falls, the vaginal and vulval lining thins, stores less glycogen, loses its protective lactobacilli and receives less blood flow, and vaginal pH climbs above 5. Clinicians call the cluster genitourinary syndrome of menopause (GSM). Reported prevalence ranges from 14% to 87%, dryness is consistently the most common complaint, and most women who have it have never been diagnosed. Unlike hot flashes, it is progressive without treatment. Indian women reach menopause around 46 on average, so this often starts in the mid-40s. Moisturisers, lubricants and, where appropriate, low-dose vaginal estrogen carry the real evidence. Any bleeding after menopause needs a doctor, without exception.
IN THIS GUIDE
1. A Word Nobody Used at Your Mother's Check-Up
2. Inside the Tissue: What Estrogen Was Holding Together
3. Where This Sits on Your Timeline
4. Six Presentations, One Underlying Cause
5. What the Evidence Actually Supports
6. Building a Daily Comfort Routine
7. Reading Supplement Claims Honestly
8. Signs That Deserve a Gynaecologist's Eye
A Word Nobody Used at Your Mother's Check-Up
In 2014, specialists retired "vaginal atrophy" in favour of genitourinary syndrome of menopause. The rewrite mattered: estrogen receptors sit in the vulva, urethra and bladder too, which is why stinging urine and painful sex are the same event wearing two costumes.
The scale is easy to underestimate. Reviews find that up to 85% of women over 40 report vaginal dryness symptoms and 29–59% report pain with sex. An Italian multicentre study found dryness the single most common sign — and noted most women identified with GSM had never been given the diagnosis.
Inside the Tissue: What Estrogen Was Holding Together
In this tissue, estrogen is less a reproductive hormone than a maintenance contract: it keeps the lining layered, keeps glycogen stocked in the surface cells, and keeps the capillary bed generous enough to lubricate on demand. Withdraw it and four things follow in sequence.
The pH shift explains a great deal. Glycogen feeds lactobacilli, lactobacilli make lactic acid, and lactic acid holds the environment near pH 3.8–4.5. Remove the glycogen and pH commonly passes 5.0 — the point at which protective flora thin out and other organisms move in. That is why recurrent urinary infections arrive in the same chapter as dryness.
Where This Sits on Your Timeline
The most useful thing an Indian woman can know is that the textbook age of 51 is not hers. A multi-region Indian study put mean natural menopause at 46.2 ± 4.9 years; a meta-analysis of Indian studies arrived at 46.6 (95% CI 44.8–48.4). National survey estimates land near 46, with real spread between states.
Stage by stage, and why dryness behaves differently from hot flashes
The trajectory matters more than the timing. Hot flashes peak and ease; genitourinary change does not. The North American Menopause Society calls it progressive in the absence of effective therapy — which is why waiting it out is the one strategy that fails.
Six Presentations, One Underlying Cause
Women who compare notes often conclude they have different problems. They usually do not — the same estrogen loss surfaces differently depending on tissue, habit and treatment history.
What the Evidence Actually Supports
Strongest evidence
• Low-dose vaginal estrogen. Described in clinical guidance as the most effective treatment for symptomatic GSM, with minimal systemic absorption at appropriate doses. A prescription decision, not a shelf one.
Good evidence, non-hormonal
-
Hyaluronic acid. A randomised pilot trial found no difference from vaginal estrogen on the primary symptom score at 12 weeks; a 2026 systematic review rates the evidence moderate quality.
-
Moisturisers and lubricants. Check pH and osmolality, not just the ingredient list — a hyperosmolar product can irritate the tissue it is meant to soothe.
Modest or unsettled
-
Oral sea buckthorn oil. In a double-blind trial, 3 g daily for three months improved vaginal epithelial integrity but produced only a favourable trend on the Vaginal Health Index. Interesting, not decisive.
-
Phytoestrogens for dryness specifically. Soy isoflavones and black cohosh have been studied for hot flashes, mood and bone. Extending those findings to dryness is an inference, not a result
Building a Daily Comfort Routine
Two distinctions do most of the work. A lubricant is for the moment of sex; a moisturiser is for the tissue, used on a schedule regardless. And an external wash cleans the vulva — it does not reach or restore the vaginal lining.
Reading Supplement Claims Honestly
House of Wellness makes UNPAUSE 40+, a non-hormonal daily tablet with doses stated per ingredient: chasteberry 100 mg, ashwagandha 60 mg, black cohosh 40 mg, soy isoflavones 40 mg, plus calcium, magnesium and vitamin D2. We would rather be precise than promotional about what that means.
Signs That Deserve a Gynaecologist's Eye
BOOK AN APPOINTMENT IF YOU HAVE
-
Any bleeding or spotting once 12 months have passed without a period — always investigated, promptly
-
Vaginal dryness symptoms, hot flashes or absent periods before age 40
-
Pain not eased after 8–12 weeks of consistent moisturiser and lubricant use
-
Burning urine, urgency, or infections that keep returning
-
Ulcers, splits, lumps or white thickened patches on the vulva, or skin that appears to be fusing
-
Discharge that is foul-smelling, bloodstained or new
-
Symptoms on an aromatase inhibitor or after cancer treatment — individualised advice, not a shelf product
Key Takeaways
-
It is a structural and chemical change in tissue — part of GSM, which also affects the vulva, urethra and bladder — not a failure of desire or hygiene.
-
Indian women experience vaginal changes after menopause around 46, so this commonly begins in the mid-40s rather than the early 50s.
-
Unlike hot flashes, it is progressive without treatment — waiting is not a plan.
-
Low-dose vaginal estrogen has the strongest evidence; hyaluronic acid and moisturisers are credible non-hormonal options.
-
No oral supplement, ours included, has been shown to resolve vaginal dryness.
-
Bleeding after menopause is never a symptom to monitor at home.
FAQs
Will this go away on its own if I wait?
Almost certainly not. Hot flashes peak and fade; genitourinary change follows the opposite curve and is described as progressive without effective therapy. It does respond to treatment at any stage, so late is far better than never.
Is coconut oil or petroleum jelly a reasonable substitute?
They are lubricants, not moisturisers: helpful in the moment, no effect on the tissue. Oils also degrade latex condoms. Guidance favours products matched to physiological pH and osmolality, since a poorly matched one can irritate fragile tissue.
I am not sexually active. Does this still need attention?
Yes. Dryness drives urgency, stinging and recurrent infections regardless of sexual activity, and the tissue keeps changing quietly. Untreated, it can make a routine smear genuinely painful.
Is vaginal estrogen the same thing as HRT?
No. It is applied locally and, at appropriate doses, systemic absorption is minimal — which is why guidance treats it differently from systemic hormone therapy. With a breast cancer history or on an aromatase inhibitor, it becomes a shared decision with your oncologist and gynaecologist.
Can a menopause supplement fix vaginal dryness?
Not on current evidence. Multi-ingredient menopause supplements are built around hot flashes, sleep, mood and bone. For dryness the effective options are topical — moisturiser, lubricant or prescription — with a supplement at best a parallel routine.
References
1. Genitourinary Syndrome of Menopause. StatPearls, NCBI Bookshelf (updated 2026). ncbi.nlm.nih.gov/books/NBK559297
2. The North American Menopause Society. Position Statement: Genitourinary Syndrome of Menopause. Menopause 2020;27(9).
3. AHRQ/PCORI Systematic Review. Genitourinary Syndrome of Menopause (2022). pcori.org
4. Palma F, et al. Vaginal atrophy of women in postmenopause: the AGATA study. Maturitas 2016;83:40–44.
5. Ahuja M. Age of menopause and determinants of menopause age: a PAN India survey. Journal of Mid-life Health 2016;7(3):126–131.
6. Prasad JB, Tyagi NK, Verma P. Age at menopause in India: a systematic review. Diabetes & Metabolic Syndrome 2021;15(1):373–377.
7. Agrawal S, et al. A randomized pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for GSM. Menopause 2024;31(9):750–755.
8. Dahab B, et al. Hyaluronic acid for vaginal health and quality of life in postmenopausal women: systematic review and meta-analysis. Int J Gynecol Obstet 2026.
9. Larmo PS, et al. Effects of sea buckthorn oil intake on vaginal atrophy in postmenopausal women. Maturitas 2014;79(3):316–321.
10. Faubion SS, et al. Genitourinary syndrome of menopause: management strategies for the clinician. Mayo Clinic Proceedings 2017;92(12):1842–1849.
11. Case-Based Perspectives on the Management of Genitourinary Syndrome of Menopause. Clinics and Practice 2026;16(3):60.
